Pfizer Vs. Gilead Sciences COVID-19 Battle Of Pharma Titans ... - Seeking Alpha
| INCR Stock | ILS 484.80 8.20 1.66% |
About 62% of Intercure's investor base is looking to short. The analysis of current outlook of investing in Intercure suggests that many traders are alarmed regarding Intercure's prospects. The current market sentiment, together with Intercure's historical and current headlines, can help investors time the market. In addition, many technical investors use Intercure stock news signals to limit their universe of possible portfolio assets.
Intercure |
Pfizer Vs. Gilead Sciences COVID-19 Battle Of Pharma Titans ... Seeking Alpha
Read at news.google.com
 |
Intercure Fundamental Analysis
We analyze Intercure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intercure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intercure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Intercure is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Intercure Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intercure stock to make a market-neutral strategy. Peer analysis of Intercure could also be used in its relative valuation, which is a method of valuing Intercure by comparing valuation metrics with similar companies.
Peers
Intercure Related Equities
| PHTM | Photomyne | 1.28 | ||||
| CBI | Clal Biotechnology | 0.57 | ||||
| BCOM | B Communications | 0.40 | ||||
| ICL | ICL Israel | 0.38 | ||||
| YHNF | M Yochananof | 0.27 | ||||
| BEZQ | Bezeq Israeli | 0.73 | ||||
| KMDA | Kamada | 1.20 | ||||
| ZNKL | Zanlakol | 1.82 |
Complementary Tools for Intercure Stock analysis
When running Intercure's price analysis, check to measure Intercure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intercure is operating at the current time. Most of Intercure's value examination focuses on studying past and present price action to predict the probability of Intercure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intercure's price. Additionally, you may evaluate how the addition of Intercure to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |